Azacitidine + Venetoclax VS Azacitidineas Maintenance Therapy in AML
Clinical trial NCT07539818 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07539818
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-29
- Primary completion
- 2030-04-01
- Enrollment
- 788
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.